IDOX PLC
30 March 2005
For immediate release 30 March 2005
IDOX plc ('IDOX' or 'the Company')
Director Shareholding
The Board of IDOX announces that it received notification on 29 March 2005 that
John Wisbey, Non-Executive Chairman, acquired, on 29 March 2005, 50,000 ordinary
shares in the Company at a price of 8.94p per share and a further 50,000
ordinary shares at a price of 9p per share. John Wisbey is now interested in a
personal capacity in 150,000 ordinary shares in IDOX representing 0.08% of the
current issued share capital.
John Wisbey also holds interests in IDOX through the shareholdings of Advanced
Technology Trust and Lombard Risk Management plc ('LRM') in IDOX. John Wisbey is
a beneficiary of Advanced Technology Trust and a director and significant
shareholder of LRM. The total beneficial interest of John Wisbey in IDOX has now
increased to 17,018,012 ordinary shares representing 9.09% of the current issued
share capital of the Company.
The ordinary shares referred to above are the ordinary shares of 1p per share.
For further information please contact:
Andrew Fraser, Chief Executive, IDOX plc 020 7954 3800
John McNicol, Company Secretary, IDOX plc 0141 574 1935
Alasdair Robinson, Noble & Company Limited 0131 225 9677
This information is provided by RNS
The company news service from the London Stock Exchange EAEDEDAESEFE
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.